Insights & Blog
In the Spotlight
Attempting to harness the body’s adaptive defense system into a drug? In this post, discover different factors to consider when trying to strike the right balance between the safety and efficacy of your antibody.
An interview with Scientific Advisor Erika Fletcher. To the clients she works with, Erika Fletcher’s sharp scientific mind is one of Immuneed’s strongest assets.
New paper featuring Immuneed. Donor-specific immune effector signatures of CLL patients in response to anti-CD20.
In-vitro whole blood analysis and its role in pre-clinical drug development
The spark behind Immuneed. An interview with founder Sara Mangsbo.